A systematic review published in 2023 examined four clinical studies involving 118 participants. The findings were promising, with some studies reporting improvements in ADHD symptoms.
Notably, a 2019 randomized, double-blind pilot study compared saffron with methylphenidate, a commonly prescribed stimulant medication. After six weeks, researchers found no statistically significant differences in symptom improvement between the two groups.
However, this does not establish that saffron is as effective as methylphenidate. The studies were small and short-term, making it difficult to draw firm conclusions about effectiveness and long-term safety.
Not based on current evidence. Although these findings warrant further investigation, larger and longer clinical trials are needed to establish saffron's effectiveness, appropriate dosing, and safety.
Additionally, saffron supplements can vary in composition and concentration, meaning commercially available products may not produce the same effects as standardized extracts used in research.
Saffron is an interesting emerging area of ADHD research, but it is not yet a validated substitute for established treatments. Individuals considering saffron supplements should consult their healthcare provider and should not change prescribed medication without medical guidance.